Skip to content

To assess usefulness of Homoeopathic medicines in adenoids and tonsil enlargment.

Homoeopathic management of symptomatic adenotonsillar hypertrophy in children: A Prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014313
Enrollment
150
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Adenotonsillar hypertrophy

Interventions

None listed

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children of the age range 3-10 years; both genders. 2 Individuals with radiological evidence of adenoidal hypertrophy (assessed on digital lateral cephalometric radiography). 3 Signs and symptoms of obstructive sleep apnoea (OSA) such as obstructive breathing during sleep, mouth breathing, snoring. 4Enlarged tonsils/adenoids. 5 Informed consent of parents/guardians who are willing to participate their children in the study and informed assent of children of age 7 and above who are willing to participate in the study. Verbal assent from the children under the age of 7 years.

Exclusion criteria

Exclusion criteria: 1Severely inflamed tonsils with high fever (more than 104 F) during screening. 2Known cranio-facial anomalies such as cleft lip, cleft palate. 3Previous tonsil, adenoid, or pharyngeal surgery. 4 Known life threatening disease/systemic illness (tuberculosis, cancer, AIDS) during screening. 5 Neuromuscular disorders, cognitive deficits or mental retardation. 6 Severe OSA requiring urgent surgery as per the engaged ENT consultant if any

Design outcomes

Primary

MeasureTime frame
1Changes in symptoms , related to ATH such as mouth breathing, snoring, Obstructive breathing during sleep at the end of 6th months of treatment. 2 Radiological changes in ATH at the end of 6 months of treatment Timepoint: 6 months

Secondary

MeasureTime frame
1 Assessment of quality of sleep at the end of 6 months of treatment. 2To identify useful medicines for adenotonsillar hypertrophy. Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Praveen Oberai

Central Council for Research in Homoeopathy

varanasiroja@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026